摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,3aR,6R,6aR)-hexahydrofuro[3,2-b]furan-3,6-diyl bis(4-(acryloyloxy)-2-methyl-benzoate) | 1346757-76-3

中文名称
——
中文别名
——
英文名称
(3R,3aR,6R,6aR)-hexahydrofuro[3,2-b]furan-3,6-diyl bis(4-(acryloyloxy)-2-methyl-benzoate)
英文别名
[(3R,3aR,6R,6aR)-6-(2-methyl-4-prop-2-enoyloxybenzoyl)oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl] 2-methyl-4-prop-2-enoyloxybenzoate
(3R,3aR,6R,6aR)-hexahydrofuro[3,2-b]furan-3,6-diyl bis(4-(acryloyloxy)-2-methyl-benzoate)化学式
CAS
1346757-76-3
化学式
C28H26O10
mdl
——
分子量
522.508
InChiKey
POUIWZSDRNCUHW-SAZLYLDSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    38
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    124
  • 氢给体数:
    0
  • 氢受体数:
    10

文献信息

  • INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE
    申请人:BARBOSA Joseph
    公开号:US20120065200A1
    公开(公告)日:2012-03-15
    Compounds are disclosed for the treatment, management and prevention of diseases and disorders affecting the bone. Particular compounds are potent inhibitors of Notum Pectinacetylesterase, and are of the formula: wherein E, G, Y, Z, R 1 , R 2 , and R 3 are defined herein.
    揭示了用于治疗、管理和预防影响骨骼的疾病和紊乱的化合物。特定的化合物是Notum果胶乙酰酶的强效抑制剂化学结构如下:其中E、G、Y、Z、R1、R2和R3如本文所定义。
  • SIMPLIFIED CONTROL OF COLOR SHIFTING PROPERTIES OF A CHIRAL LIQUID CRYSTAL POLYMER
    申请人:CALLEGARI Andrea
    公开号:US20120141745A1
    公开(公告)日:2012-06-07
    A chiral liquid crystal precursor composition which comprises at least one salt that changes a position of the selective reflection band exhibited by the composition in a cured state compared to the position of a selective reflection band exhibited by a composition in the cured state that does not contain the at least one salt. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    一种手性液晶前体组成物,其包括至少一种盐,该盐与不含该至少一种盐的固化状态下的组成物所展示的选择性反射带的位置相比,会改变该组成物在固化状态下所展示的选择性反射带的位置。本摘要既不旨在定义本说明书中所披露的发明,也不旨在以任何方式限制发明的范围。
  • Composite marking based on chiral liquid crystal precursors and modifying resins
    申请人:SICPA HOLDING SA
    公开号:US10308872B2
    公开(公告)日:2019-06-04
    Disclosed is a substrate which has thereon a marking or layer comprising a cured chiral liquid crystal precursor composition which does not contain any salt that would change the position of a selective reflection band exhibited by the cured composition. A modifying resin made from one or more polymerizable monomers comprising an average of at least one ether functionali typer polymerizable group is disposed between the substrate and the marking or layer and in contact with the marking or layer in one or more areas thereof. The modifying resin changes the position of a selective reflection band exhibited by the cured chiral liquid crystal precursor composition on the substrate in the one or more areas.
    本发明公开了一种基底,该基底上有一个包含固化手性液晶前驱体组合物的标记或层,该组合物不含任何会改变固化组合物所显示的选择性反射带位置的盐。改性树脂由一种或多种可聚合单体制成,这些单体平均含有至少一个醚官能团型可聚合基团,被置于基底和标记或层之间,并在一个或多个区域与标记或层接触。改性树脂可改变固化手性液晶前驱体组合物在基底上一个或多个区域中显示的选择性反射带的位置。
  • Salt-free composite marking based on chiral liquid crystal precursors comprising chiral acrylate dopants
    申请人:SICPA HOLDING SA
    公开号:US10611919B2
    公开(公告)日:2020-04-07
    Disclosed is a substrate which has thereon a marking or layer comprising a salt-free cured chiral liquid crystal precursor composition which comprises one or more nematic compounds A and one or more chiral dopant compounds B which are capable of giving rise to a cholesteric state of the chiral liquid crystal precursor composition and are of formula (I) as set forth herein. A modifying resin made from one or more polymerizable monomers comprising an average of at least one ether functionality per polymerizable group is disposed between the substrate and the marking or layer and in contact with the marking or layer in one or more areas thereof. The modifying resin changes the position of a selective reflection band exhibited by the cured chiral liquid crystal precursor composition on the substrate in the one or more areas.
    本发明公开了一种基底,该基底上有一个标记或层,该标记或层包括无盐固化手性液晶前体组合物,该组合物包括一种或多种向列化合物 A 和一种或多种手性掺杂化合物 B,这些化合物能使手性液晶前体组合物产生胆甾态,并如本文所述的式 (I)。由一种或多种可聚合单体制成的改性树脂,平均每个可聚合基团含有至少一个醚官能团,置于基底和标记或层之间,并在一个或多个区域与标记或层接触。改性树脂可改变基底上固化的手性液晶前驱体组合物在一个或多个区域中显示的选择性反射带的位置。
  • IDENTIFICATION AND AUTHENTICATION USING LIQUID CRYSTAL MATERIAL MARKINGS
    申请人:SICPA HOLDING SA
    公开号:EP2285587B1
    公开(公告)日:2016-11-23
查看更多

同类化合物

顺式-2,3,3a,6a-四氢呋喃[2,3-b]呋喃 莱克酮 索尼地平 硝酸异山梨酯 溴化二氢6-(联苯基-4-基)-3-氯-12,13-二甲氧基-9,10--7H-异奎并[2,1-d][1,4]苯并二氮卓-8-正离子 星形曲霉毒素 抗坏血酸原 A 异山梨醇二甲基醚 异山梨醇13C65-单酸酯 异山梨醇 失水甘露醇单油酸酯 失水甘露醇单油酸酯 大青素 地瑞那韦中间体1 四氢呋喃[2,3-B]呋喃-2(6AH)-酮 四氢-6a-甲基-呋喃并[2,3-b]呋喃-2(3H)-酮 四氢-6-硫代-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3-酮 去甲斑蝥素 单硝酸异山梨酯杂质C 单-9-十八烯酸1,4:3,6-双脱水-D-甘露醇酯 华北白前甙元B 六氢呋喃并[2,3-b]呋喃-3-醇 六氢呋喃并[2,3-b]呋喃 六氢-呋喃并[2,3-b]呋喃-3-醇 克罗拉滨杂质7 二氯萘 二氢-1,4-二甲基-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二酮 二氢-1,4-乙桥-1H,3H-呋喃并(3,4-c)呋喃-3,6(4H)-二硫酮 乙酸异山梨醇酯 丙氨酸,N-(5-氯-2-羟基苯甲酰)- N-乙酰基-L-丙氨酰-L-酪氨酸 L-葡糖酸-3,6-内酯 D-葡糖醛酸-γ-内酯丙酮化合物 D-甘露呋喃糖醛酸 gamma-内酯 BISTHFHNS衍生物3 7H,10H-呋喃并[2,3,4-cd]萘并[2,1-e]异苯并呋喃-7-酮,十四氢-10-羟基-1,1,4a-三甲基-,(4aS,4bR,6aR,8aR,10R,10aS,10bR,12aS)-(9CI) 7-氧杂二环[2.2.1]庚-5-烯-2,3-二羧酸酐 6H,9H-苯并[e]呋喃并[2,3,4-cd]异苯并呋喃-6-酮,2,4,4a,5,7,8,10a,10b-八氢-5,5-二甲基-,(4aR,8aR,10aR,10bS)-(9CI) 6-[(1E,3E,5E)-6-[(1R,2R,3R,5R,7R,8R)-7-乙基-2,8-二羟基-1,8-二甲基L-4,6-二氧杂双环[3.3.0]辛-3-基]己-1,3,5-三烯基]-4-甲氧基-5-甲基-吡喃-2-酮 5-单硝酸异山梨酯 5-乙酸异山梨酯 5-乙酸异山梨酯 5-[(4,6-二氯-1,3,5-三嗪-2-基)氨基]-4-羟基-3-[(4-磺酸根-1-萘基)偶氮]萘-2,7-二磺化三钠 5,6-二溴-7-氧杂双环[2.2.1]庚烷-2,3-二甲酸酐 5,5-二甲基-4,8-二氧杂三环[4.2.1.03,7]壬-2-基丙烯酸酯 4-硝基苯并[pqr]四苯-1-醇 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3-酮 4,10-二氧杂三环[5.2.1.0(2,6)]癸-8-烯-3,5-二酮 3-脱氧-14,15-二氢-15-羟基-莸酯素醇